Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 4, 1998, Pages 621-628

  Du, Xiao Jun ^a   Woodcock, Elizabeth A ^a   Little, Peter J ^a   Esler, Murray D ^a   Dart, Anthony M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Anoxia; Inositol 1,4,5 trisphosphate; Ischemia; Norepinephrine; Uptake 1 inhibitor; Ventricular fibrillation

Indexed keywords

COCAINE; DESIPRAMINE; HEPARIN; IMIPRAMINE; INOSITOL TRISPHOSPHATE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PENTOBARBITAL; PRAZOSIN; RESERPINE; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOXIA; ARTICLE; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; DRUG TISSUE LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANOXIA; COCAINE; DESIPRAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; IMIPRAMINE; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; VENTRICULAR FIBRILLATION;

EID: 0031680644     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199810000-00015     Document Type: Article

References (37)

1. Schömig A. Catecholamines in myocardial ischemia: systemic and cardiac release. Circulation 1990;82(suppl):II-13-22.
2. Dart AM, Du X-J. Unexpected drug effects on autonomic function during myocardial ischaemia. Cardiovasc Res 1993;27:906-14.
3. Bril A, Rochette L. Antiarrhythmic properties of antidepressant drugs after coronary artery occlusion and reperfusion in rats. Pharmacology 1988;36:16-26.
4. Daugherty A, Frayn KN, Redfern WS, Woodward B. The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro. Br J Pharmacol 1986; 87:265-77.
5. Dietz R, Offner B, Dart AM, Schömig A. Ischaemia induced noradrenaline release mediates ventricular arrhythmias. In: Brachmann JM, Schömig A, eds. Adrenergic system and ventricular arrhythmias in ventricular arrhythmias in myocardial infarction. Berlin: Springer-Verlag, 1989:313-21.
6. Anderson KE, Dart AM, Woodcock EA. Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart. Circ Res 1995;76:261-8.
7. 3 release. Circulation 1995;91:2712-6.
8. 3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Circ Res 1996;78:475-81.
9. Kurz T, Offner B, Schreieck J, Richardt G, Tolg R, Schömig A. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts. Naunyn Schmiedebergs Arch Pharmacol 1995;352:491-6.
10. Schömig A, Kurz T, Richardt G, Schömig E. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic heart: mechanism and metabolic requirements. Circ Res 1987;60:194-205.
11. Du X-J, Dart AM. Mechanisms of noradrenaline release in the anoxic heart of the rat. Cardiovasc Res 1993;27:2011-5.
12. Shindo T, Akiyama T, Yamazaki T, Ninomiya I. Regional myocardial interstitial norepinephrine kinetics during coronary occlusion and reperfusion. Am J Physiol 1996;270:H245-51.
13. Walker M, Curtis M, Jearse D, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988;22:447-55.
14. i in energy deprivation contracture. Circ Res 1987;61:726-34.
15. Koretsune Y, Marban E. Cell calcium in the pathophysiology of ventricular fibrillalion and in the pathogenesis of postarrhythmic contractile dysfunction. Circulation 1989;80:369-79.
16. Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Naunyn Schmiedebergs Arch Pharmacol 1990;341:192-9.
17. Du X-J, Bobik A, Little PJ, Esler MD, Dart AM. Role of calcium in metabolic inhibition-induced norepinephrine release in rat brain synaptosomes. Circ Res 1997;80:179-88.
18. Firestone JA, Gerhardt GA, DeBernardis JF, McKelvy JF, Browning MD. Action of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells. J Pharmacol Exp Ther 1993;264:1206-10.
19. 2+ exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ Res 1991;69:1632-9.
20. Sheridan DJ. Alpha adrenoceptors and arrhythmias. J Mol Cell Cardiol 1986;18(suppl 5):59-68.
21. Nayler WG, Gordon DJ, Stephens DJ, Sturrock WJ. The protective effect of prazosin on the ischaemic and reperfused myocardium. J Mol Cell Cardiol 1988;17:685-99.
22. 1-adrenergic receptor subtype. Circulation 1991;83:2076-82.
23. Bralet J, Didier JP, Moreau D, Opie LH, Rochette L. Effect of α-adrenoceptor antagonists (phentolamine, nicergoline and prazosin) on reperfusion arrhythmias and noradrenaline release in perfused rat heart. Br J Pharmacol 1985;84:9-18.
24. Curtis MJ, Pugsley MK, Walker MJA. Endogenous chemical mediators of ventricular arrhythmias in ischemic heart disease. Cardiovasc Res 1993;27:703-19.
25. Williams FM, Rochette L, Kane KA, Parratt JR. Effects of alterations in sympathetic nervous activity on the severity of reperfusion-induced arrhythmias in anaesthetised rats. J Cardiovasc Pharmacol 1987;10:555-61.
26. Metz V, Bernauer W. The effect of reserpine and guanethidine on carbohydrate metabolism in ischaemic rat myocardium Cardiovasc Res 1989;23:385-9.
27. Cross HR, Opie LH, Radda GK, Clarke K. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? Circ Res 1996;78:482-91.
28. Murphy E, Perlman L, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res 1991;68:1250-8.
29. 2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ Res 1989;65:1045-56.
30. + exchange inhibitor and its effects in cardiac ischaemia. Br J Pharmacol 1993;109:562-8.
31. Muir WW, Struch SM, Schaal SF. Effects of tricyclic antidepressant drugs on the electrophysiological properties of dog Purkinje fibers. J Cardiovasc Pharmacol 1982;4:82-90.
32. Robert E, Bruelle P, de La Coussaye JE, et al. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts. J Pharmacol Exp Ther 1996;278:170-8.
33. Nishida M, Borzak S, Kraemer B, et al. Role of cation gradients in hypercontracture of myocytes during simulated ischemia and reperfusion. Am J Physiol 1993;264:H1896-906.
34. 3H]imipramine in bovine adrenal medullary cells. J Pharmacol Exp Ther 1987;243:342-8.
35. 2+ exchange in rat brain cortex synaptosomes. Can J Physiol Pharmacol 1990;68: 1414-8.
36. Raskind M, Veith R, Barnes R, Gumbrecht G. Cardiovascular and antidepressant effects of imipramine in the treatment of secondary depression in patients with ischemic heart disease. Am J Psychiatry 1982;139:1114-7.
37. The CAPS Coordinating Center. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS: The cardiac arrhythmia pilot study (CAPS) investigators. Am J Cardiol 1988;61: 501-9.